U.S. RESEARCH ROUNDUP- Bed Bath & Beyond, Huntington Ingalls Industries, Ra Pharma

Myers Industries

15/10/2019 09:00

Oct 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Bed Bath & Beyond, Premier and Repay Holdings on
Tuesday. 
    
    HIGHLIGHTS
     * Bed Bath & Beyond Inc  BBBY.O : KeyBanc raises to overweight from sector weight
     * Huntington Ingalls Industries Inc  HII.N : Melius Research raises to overweight rating
     * Premier Inc  PINC.O : Canaccord Genuity raises to buy rating
     * Ra Pharmaceuticals Inc  RARX.O : Credit Suisse cuts to neutral from outperform
     * Repay Holdings Corp  RPAY.O : BTIG raises target price to $16 from $15
        
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
   
     * Algonquin Power & Utilities Corp  AQN.N : CIBC raises target price to $14.25 from $13.5
     * ASML Holding  ASML.O : Bernstein raises target price to $232 from $195
     * Bed Bath & Beyond Inc  BBBY.O : KeyBanc raises to overweight from sector weight
     * Canadian Solar Inc  CSIQ.O : JP Morgan cuts target price to $25 from $28
     * Encana Corp  ECA.N : CIBC cuts target price to $5 from $7
     * Huntington Ingalls Industries Inc  HII.N : Melius Research raises price target to $295
     * Huntington Ingalls Industries Inc  HII.N : Melius Research raises to overweight rating
     * Independence Contract Drilling  ICD.N : Cowen and Company raises PT to $1.20 from $0.75
     * Myers Industries Inc  MYE.N : JP Morgan cuts Dec 2020 target price to $19 from $21
     * Owens-Illinois Inc  OI.N : JP Morgan cuts target price to $13 from $15
     * Premier Inc  PINC.O : Canaccord Genuity raises to buy rating
     * Ra Pharmaceuticals Inc  RARX.O : Credit Suisse cuts to neutral from outperform
     * Ra Pharmaceuticals Inc  RARX.O : Credit Suisse raises target price to $48 from $32
     * Repay Holdings Corp  RPAY.O : BTIG raises target price to $16 from $15
     * Stealth Biotherapeutics Corp  MITO.O : Jefferies cuts target price to $9.00 from $14
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))